Cost-effectiveness of Escitalopram vs. Venlafaxin XR in the treatment of major depressive disorder in Germany

被引：1
|
作者：
Kulp, W [1 ]
Greiner, W [1 ]
Schulenburg, JM [1 ]
机构：
[1] Univ Hannover, Hannover, Germany
来源：
VALUE IN HEALTH | 2005年 / 8卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)63062-8
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：392 / 393
页数：2
相关论文
共 50 条
  • [41] Cost-utility comparison of escitalopram and sertraline in the treatment of major depressive disorder
    Armstrong, Edward P.
    Skrepnek, Grant H.
    Erder, M. Haim
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (02) : 251 - 258
  • [42] COST-EFFECTIVENESS OF INFLECTRA® VS. REMICADE® FOR ANKYLOSING SPONDYLITIS IN GERMANY
    Gissel, C.
    Lange, U.
    Uhrmann, M. F.
    VALUE IN HEALTH, 2017, 20 (09) : A536 - A536
  • [43] COST-EFFECTIVENESS OF AGOMELATINE IN TREATMENT OF MAJOR DEPRESSIVE DISORDERS IN TURKEY
    Tatar, M.
    Dilbaz, N.
    Oral, E. T.
    Tan, M.
    VALUE IN HEALTH, 2012, 15 (04) : A88 - A88
  • [44] COST-EFFECTIVENESS OF AGOMELATINE IN THE TREATMENT OF MAJOR DEPRESSIVE EPISODES IN THAILAND
    Prukkanone, B.
    Kongsuk, T.
    VALUE IN HEALTH, 2011, 14 (07) : A292 - A292
  • [45] Cost-effectiveness of escitalopram for generalized anxiety disorder in Canada
    Iskedjian, Michael
    Walker, John H.
    Bereza, Basil G.
    Le Melledo, Jean-Michel
    Einarson, Thomas R.
    CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (05) : 1539 - 1548
  • [46] Cost-Effectiveness of Combinatorial Pharmacogenomic Testing for Treatment-Resistant Major Depressive Disorder Patients
    Hornberger, John
    Li, Qianyi
    Quinn, Bruce
    AMERICAN JOURNAL OF MANAGED CARE, 2015, 21 (06): : E357 - +
  • [47] Cost-effectiveness of olanzapine vs. aripiprazole in the treatment of schizophrenia
    Ascher-Svanum, Haya
    Stensland, Michael D.
    Peng, Xiaomei
    Faries, Douglas E.
    Stauffer, Virginia L.
    Osuntokun, Olawale O.
    Kane, John M.
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (01) : 115 - 122
  • [48] AN ASSESSEMENT OF THE COST-EFFECTIVENESS OF ESCITALOPRAM VERSUS MULTIPLE COMPARATORS AS FIRST LINE ANTIDEPRESSANT IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER (MDD) IN BELGIUM
    Druais, S.
    Gauthier, A.
    Demyttenaere, K.
    Brignone, M.
    De Pauw, A.
    Defraigne, G.
    Annemans, L.
    VALUE IN HEALTH, 2012, 15 (07) : A338 - A338
  • [49] Escitalopram and citalopram in the treatment of outpatients with major depressive disorder
    Moore, N
    Verdoux, H
    Fantino, B
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S426 - S426
  • [50] Comparative efficacy of escitalopram in the treatment of major depressive disorder
    Ali, Mazen K.
    Lam, Raymond W.
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2011, 7 : 39 - 49
12345